News Industry News Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure October 28, 2013
News Industry News First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich’s COMBO Dual Therapy Stent™ in Routine Practice August 06, 2013
News Industry News Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference October 18, 2012